Pacific Biosciences of California, Inc. Operating Income
Pacific Biosciences of California, Inc. (PACB) reported Operating Income of -$44.61 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-06
- Pacific Biosciences of California, Inc. operating income (loss) for the quarter ending 2026-06-30 was -$44.61M.
- Pacific Biosciences of California, Inc. operating income (loss) for the quarter ending 2026-03-31 was -$8.36M.
- Pacific Biosciences of California, Inc. operating income (loss) for the quarter ending 2025-12-31 was -$41.20M.
- Pacific Biosciences of California, Inc. operating income (loss) for the quarter ending 2025-09-30 was -$38.88M.
- Pacific Biosciences of California, Inc. operating income (loss) for fiscal 2025 was -$553.86M.
- Pacific Biosciences of California, Inc. operating income (loss) for fiscal 2024 was -$474.31M.
- Pacific Biosciences of California, Inc. operating income (loss) for fiscal 2023 was -$334.47M.
- Pacific Biosciences of California, Inc. operating income (loss) for fiscal 2022 was -$307.20M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$44.61M 10-Q · filed 2026-08-06 | -$52.97M 10-Q · filed 2026-08-06 | -$94.16M derived: sum of 3 quarters · filed 2026-08-06 | -$133.04M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$8.36M 10-Q · filed 2026-05-08 | -$49.55M derived: sum of 2 quarters · filed 2026-05-08 | -$88.43M derived: sum of 3 quarters · filed 2026-05-08 | -$133.28M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$41.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$80.07M derived: sum of 2 quarters · filed 2026-02-25 | -$124.93M derived: sum of 3 quarters · filed 2026-08-06 | -$553.86M 10-K · filed 2026-02-25 |
| 2025-09-30 | -$38.88M 10-Q · filed 2025-11-06 | -$83.73M derived: sum of 2 quarters · filed 2026-08-06 | -$512.66M 10-Q · filed 2025-11-06 | -$665.69M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$44.85M 10-Q · filed 2026-08-06 | -$473.79M 10-Q · filed 2026-08-06 | -$626.82M derived: sum of 3 quarters · filed 2026-08-06 | -$690.89M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$428.93M 10-Q · filed 2026-05-08 | -$581.96M derived: sum of 2 quarters · filed 2026-05-08 | -$646.04M derived: sum of 3 quarters · filed 2026-05-08 | -$821.88M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$153.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$217.10M derived: sum of 2 quarters · filed 2026-02-25 | -$392.95M derived: sum of 3 quarters · filed 2026-02-25 | -$474.31M 10-K · filed 2026-02-25 |
| 2024-09-30 | -$64.08M 10-Q · filed 2025-11-06 | -$239.92M derived: sum of 2 quarters · filed 2025-11-06 | -$321.29M 10-Q · filed 2025-11-06 | -$408.83M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | -$175.85M 10-Q · filed 2025-08-07 | -$257.21M 10-Q · filed 2025-08-07 | -$344.76M derived: sum of 3 quarters · filed 2026-02-25 | -$427.25M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | -$81.36M 10-Q · filed 2025-05-12 | -$168.91M derived: sum of 2 quarters · filed 2026-02-25 | -$251.40M derived: sum of 3 quarters · filed 2026-02-25 | -$324.58M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | -$87.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$170.04M derived: sum of 2 quarters · filed 2026-02-25 | -$243.22M derived: sum of 3 quarters · filed 2026-02-25 | -$334.47M 10-K · filed 2026-02-25 |
| 2023-09-30 | -$82.49M 10-Q · filed 2024-11-12 | -$155.67M derived: sum of 2 quarters · filed 2024-11-12 | -$246.92M 10-Q · filed 2024-11-12 | -$334.00M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-06-30 | -$73.17M 10-Q · filed 2024-08-09 | -$164.43M 10-Q · filed 2024-08-09 | -$251.51M derived: sum of 3 quarters · filed 2025-03-17 | -$326.13M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-03-31 | -$91.25M 10-Q · filed 2024-05-09 | -$178.34M derived: sum of 2 quarters · filed 2025-03-17 | -$252.96M derived: sum of 3 quarters · filed 2025-03-17 | -$320.93M derived: sum of 4 quarters · filed 2025-03-17 |
| 2022-12-31 | -$87.08M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | -$161.70M derived: sum of 2 quarters · filed 2025-03-17 | -$229.67M derived: sum of 3 quarters · filed 2025-03-17 | -$307.20M 10-K · filed 2025-03-17 |
| 2022-09-30 | -$74.62M 10-Q · filed 2023-11-03 | -$142.59M derived: sum of 2 quarters · filed 2023-11-03 | -$220.11M 10-Q · filed 2023-11-03 | -$284.79M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | -$67.97M 10-Q · filed 2023-08-04 | -$145.49M 10-Q · filed 2023-08-04 | -$210.17M derived: sum of 3 quarters · filed 2024-02-28 | -$284.64M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | -$77.52M 10-Q · filed 2023-05-04 | -$142.20M derived: sum of 2 quarters · filed 2024-02-28 | -$216.68M derived: sum of 3 quarters · filed 2024-02-28 | -$254.25M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$64.68M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$139.15M derived: sum of 2 quarters · filed 2024-02-28 | -$176.72M derived: sum of 3 quarters · filed 2024-02-28 | -$210.44M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$74.48M 10-Q · filed 2022-11-08 | -$112.05M derived: sum of 2 quarters · filed 2022-11-08 | -$145.76M 10-Q · filed 2022-11-08 | -$169.74M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$37.57M 10-Q · filed 2022-08-08 | -$71.28M 10-Q · filed 2022-08-08 | -$95.26M derived: sum of 3 quarters · filed 2023-02-28 | -$119.44M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$33.71M 10-Q · filed 2022-05-06 | -$57.69M derived: sum of 2 quarters · filed 2023-02-28 | -$81.86M derived: sum of 3 quarters · filed 2023-02-28 | -$105.39M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$23.98M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$48.15M derived: sum of 2 quarters · filed 2023-02-28 | -$71.68M derived: sum of 3 quarters · filed 2023-02-28 | -$104.39M 10-K · filed 2023-02-28 |
| 2020-09-30 | -$24.18M 10-Q · filed 2021-11-05 | -$47.70M derived: sum of 2 quarters · filed 2021-11-05 | -$80.41M 10-Q · filed 2021-11-05 | -$98.33M derived: sum of 4 quarters · filed 2021-11-05 |
| 2020-06-30 | -$23.52M 10-Q · filed 2021-08-06 | -$56.23M 10-Q · filed 2021-08-06 | -$74.15M derived: sum of 3 quarters · filed 2021-08-06 | -$102.26M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | -$32.71M 10-Q · filed 2021-05-06 | -$50.63M derived: sum of 2 quarters · filed 2021-05-06 | -$78.74M derived: sum of 3 quarters · filed 2021-05-06 | -$103.12M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | -$17.92M 10-K · filed 2020-02-28 | -$46.03M derived: sum of 2 quarters · filed 2020-11-03 | -$70.41M derived: sum of 3 quarters · filed 2020-11-03 | -$100.55M 10-K · filed 2022-02-28 |
| 2019-09-30 | -$28.11M 10-Q · filed 2020-11-03 | -$52.49M derived: sum of 2 quarters · filed 2020-11-03 | -$82.63M 10-Q · filed 2020-11-03 | -$113.25M derived: sum of 4 quarters · filed 2020-11-03 |
| 2019-06-30 | -$24.38M 10-Q · filed 2020-08-06 | -$54.51M 10-Q · filed 2020-08-06 | -$85.14M derived: sum of 3 quarters · filed 2020-08-06 | -$109.81M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | -$30.13M 10-Q · filed 2020-05-08 | -$60.76M derived: sum of 2 quarters · filed 2020-05-08 | -$85.43M derived: sum of 3 quarters · filed 2020-05-08 | -$107.17M derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | -$30.62M 10-K · filed 2020-02-28 | -$55.29M derived: sum of 2 quarters · filed 2020-02-28 | -$77.04M derived: sum of 3 quarters · filed 2020-02-28 | -$100.99M 10-K · filed 2021-02-26 |
| 2018-09-30 | -$24.67M 10-K · filed 2020-02-28 | -$46.41M derived: sum of 2 quarters · filed 2020-02-28 | -$70.36M 10-Q · filed 2019-11-07 | -$90.89M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | -$21.75M 10-K · filed 2020-02-28 | -$45.69M 10-Q · filed 2019-08-06 | -$66.22M derived: sum of 3 quarters · filed 2020-02-28 | -$87.79M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | -$23.95M 10-K · filed 2020-02-28 | -$44.48M derived: sum of 2 quarters · filed 2020-02-28 | -$66.05M derived: sum of 3 quarters · filed 2020-02-28 | -$90.43M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | -$20.53M 10-K · filed 2019-02-26 | -$42.10M derived: sum of 2 quarters · filed 2019-02-26 | -$66.48M derived: sum of 3 quarters · filed 2019-02-26 | -$89.78M 10-K · filed 2020-02-28 |
| 2017-09-30 | -$21.57M 10-K · filed 2019-02-26 | -$45.96M derived: sum of 2 quarters · filed 2019-02-26 | -$69.25M 10-Q · filed 2018-11-05 | -$87.13M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | -$24.39M 10-K · filed 2019-02-26 | -$47.69M 10-Q · filed 2018-08-03 | -$65.56M derived: sum of 3 quarters · filed 2019-02-26 | -$82.30M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | -$23.30M 10-K · filed 2019-02-26 | -$41.17M derived: sum of 2 quarters · filed 2019-02-26 | -$57.91M derived: sum of 3 quarters · filed 2019-02-26 | -$75.98M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | -$17.87M 10-K · filed 2018-02-26 | -$34.61M derived: sum of 2 quarters · filed 2018-02-26 | -$52.68M derived: sum of 3 quarters · filed 2018-02-26 | -$71.24M 10-K · filed 2019-02-26 |
| 2016-09-30 | -$16.73M 10-K · filed 2018-02-26 | -$34.80M derived: sum of 2 quarters · filed 2018-02-26 | -$53.37M 10-Q · filed 2017-11-02 | -$54.43M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | -$18.07M 10-K · filed 2018-02-26 | -$36.63M 10-Q · filed 2017-08-02 | -$37.70M derived: sum of 3 quarters · filed 2018-02-26 | -$35.08M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | -$18.57M 10-K · filed 2018-02-26 | -$19.63M derived: sum of 2 quarters · filed 2018-02-26 | -$17.01M derived: sum of 3 quarters · filed 2018-02-26 | -$28.37M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | -$1.06M 10-K · filed 2017-03-06 | $1.55M derived: sum of 2 quarters · filed 2017-03-06 | -$9.81M derived: sum of 3 quarters · filed 2017-03-06 | -$29.13M 10-K · filed 2018-02-26 |
| 2015-09-30 | $2.61M 10-K · filed 2017-03-06 | -$8.74M derived: sum of 2 quarters · filed 2017-03-06 | -$28.07M 10-Q · filed 2016-11-04 | -$45.97M derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-06-30 | -$11.36M 10-K · filed 2017-03-06 | -$30.69M 10-Q · filed 2016-08-04 | -$48.58M derived: sum of 3 quarters · filed 2017-03-06 | -$56.99M derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-03-31 | -$19.33M 10-K · filed 2017-03-06 | -$37.22M derived: sum of 2 quarters · filed 2017-03-06 | -$45.63M derived: sum of 3 quarters · filed 2017-03-06 | -$63.94M derived: sum of 4 quarters · filed 2017-03-06 |
| 2014-12-31 | -$17.89M 10-K · filed 2016-03-11 | -$26.31M derived: sum of 2 quarters · filed 2016-03-11 | -$44.61M derived: sum of 3 quarters · filed 2016-03-11 | -$62.85M 10-K · filed 2017-03-06 |
| 2014-09-30 | -$8.41M 10-K · filed 2016-03-11 | -$26.71M derived: sum of 2 quarters · filed 2016-03-11 | -$44.96M 10-Q · filed 2015-11-05 | -$61.96M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-06-30 | -$18.30M 10-K · filed 2016-03-11 | -$36.55M 10-Q · filed 2015-08-05 | -$53.55M derived: sum of 3 quarters · filed 2016-03-11 | -$73.49M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-03-31 | -$18.25M 10-K · filed 2016-03-11 | -$35.25M derived: sum of 2 quarters · filed 2016-03-11 | -$55.18M derived: sum of 3 quarters · filed 2016-03-11 | -$75.18M derived: sum of 4 quarters · filed 2016-03-11 |
| 2013-12-31 | -$17.00M 10-K · filed 2015-03-12 | -$36.94M derived: sum of 2 quarters · filed 2015-03-12 | -$56.94M derived: sum of 3 quarters · filed 2015-03-12 | -$77.54M 10-K · filed 2016-03-11 |
| 2013-09-30 | -$19.93M 10-K · filed 2015-03-12 | -$39.93M derived: sum of 2 quarters · filed 2015-03-12 | -$60.54M 10-Q · filed 2014-11-05 | -$82.23M derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-06-30 | -$20.00M 10-K · filed 2015-03-12 | -$40.60M 10-Q · filed 2014-08-05 | -$62.30M derived: sum of 3 quarters · filed 2015-03-12 | -$84.88M derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-03-31 | -$20.61M 10-K · filed 2015-03-12 | -$42.30M derived: sum of 2 quarters · filed 2015-03-12 | -$64.88M derived: sum of 3 quarters · filed 2015-03-12 | -$87.44M derived: sum of 4 quarters · filed 2015-03-12 |
| 2012-12-31 | -$21.69M 10-K · filed 2014-03-14 | -$44.27M derived: sum of 2 quarters · filed 2014-03-14 | -$66.83M derived: sum of 3 quarters · filed 2014-03-14 | -$94.34M 10-K · filed 2015-03-12 |
| 2012-09-30 | -$22.58M 10-K · filed 2014-03-14 | -$45.13M derived: sum of 2 quarters · filed 2014-03-14 | -$72.64M 10-Q · filed 2013-11-12 | |
| 2012-06-30 | -$22.55M 10-K · filed 2014-03-14 | -$50.06M 10-Q · filed 2013-08-09 | ||
| 2012-03-31 | -$27.51M 10-K · filed 2014-03-14 | |||
| 2011-12-31 | -$109.76M 10-K · filed 2014-03-14 | |||
| 2011-03-31 | -$34.97M 10-Q · filed 2012-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |